<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>ccRCC immunotherapy &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/ccrcc-immunotherapy/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Mon, 26 Jan 2026 10:19:12 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>ccRCC immunotherapy &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Blocking Glutamine Metabolism Hinders Tumor Growth and Enhances Immunotherapy</title>
		<link>https://bioengineer.org/blocking-glutamine-metabolism-hinders-tumor-growth-and-enhances-immunotherapy/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Mon, 26 Jan 2026 10:18:43 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[**Etiketler:** glutamine metabolism]]></category>
		<category><![CDATA[2. **Renal cell carcinoma** (çalışmanın odaklandığı kanser türü)]]></category>
		<category><![CDATA[3]]></category>
		<category><![CDATA[ccRCC immunotherapy]]></category>
		<category><![CDATA[Combination cancer therapy]]></category>
		<category><![CDATA[Glutamine metabolism inhibition]]></category>
		<category><![CDATA[immune checkpoint blockade]]></category>
		<category><![CDATA[immune checkpoint blockade enhancement]]></category>
		<category><![CDATA[metabolic inhibitors **Açıklama:** Bu etiketler makalenin temel odak noktalarını kapsar: 1. **Glutamine metabolism** (ana araştırma konusu)]]></category>
		<category><![CDATA[Renal cell carcinoma]]></category>
		<category><![CDATA[tumor growth inhibition]]></category>
		<category><![CDATA[Tumor growth suppression]]></category>
		<guid isPermaLink="false">https://bioengineer.org/blocking-glutamine-metabolism-hinders-tumor-growth-and-enhances-immunotherapy/</guid>

					<description><![CDATA[Recent studies have shed light on the complex interplay between metabolism and cancer progression, particularly in the context of renal cell carcinoma (RCC). The latest research, led by Ma et al., investigates how inhibiting glutamine metabolism can serve as a powerful strategy against ccRCC, a subtype of kidney cancer. This groundbreaking work opens new avenues [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">321012</post-id>	</item>
	</channel>
</rss>
